Study: NCT05144984

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.